PolyPid Announces Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX to 800 Patients with a Concurrent Private Placement of up to $41 Million
December 23, 2024 19:22 ET | Source: PolyPid Ltd. • 630 Patients…
Search
Have an existing account?
Sign In
Tag: $41